Browse > Article
http://dx.doi.org/10.15432/JKTO.2016.21.1.015

Treatment of Cancer of Unknown Primary Site Patient with Traditional Korean Medicine : A Case Report  

Kim, JeeHye (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Bae, KyeoRe (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Park, JiHye (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Park, SoJung (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Cho, ChongKwan (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Yoo, HwaSeung (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon)
Publication Information
Journal of Korean Traditional Oncology / v.21, no.1, 2016 , pp. 15-25 More about this Journal
Abstract
Objective : The purpose of this study is to report the possibility of treatment of Cancer of Unknown Primary Site (CUPS) patient with Traditional Korean Medicine based Samchilchoongcho-jung and Gunchilgyebok-Jung following chemotherapy. Methods : The patient is a female, who was diagnosed with CUPS, suffering from left flank pain, abdominal discomfort, nausea, vomiting and fatigue after chemotherapy. The patient was treated with acupuncture, pharmacoacupuncture, moxibution, herbal medicine and enema used with herbal decoction for 15 days. The clinical outcomes were measured by numeric rating scale(NRS). Results : After treatment, left flank pain had disappeared and nausea and vomiting was decreased from NRS 4 to NRS 1 respectively. Fatigue was also improved. Conclusion : This case study suggests that Traditional Korean Medicine is effective for treatment of CUPS patients and can improve the quality of life.
Keywords
Cancer of Unknown Primary Site (CUPS); Metastasis of Unknown Origin (MUO); Traditional Korean Medicine; Samchilchoongcho-jung; Gunchilgyebok-Jung;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Lee JO, Moon JW, Lee SK, Kim SM, Kim N, Ko SG, Kim HS, Park SH. Rhus verniciflau Extract Modulates Survival of MCF-7 Breast Cancer cells through the modulation of AMPK-pathway. Biol. Pharm. Bull. 37(5):794-801, 2014   DOI
2 김성학, 김경준. 건칠이 혈관신생관련 단백질 발현에 미치는 영향. 한의안이비인후피부과학회지 19(3):1-12, 2006
3 황덕상, 조정훈, 장준복, 이경섭. 계지복령환의 Hela cell 증식억제와 사멸효과. 대한한의학회지 27(1):23-35, 2006
4 윤성우, 박재우, 김경식, 정현식, 최원철. 건칠추출물(Nexia)의 독성 실험과 급성림프구성 백혈병환자의 임상증례군 보고. 대한암한의학회지 11(1):1-21, 2006
5 김은희, 박소정, 최원철, 이수경. 알러젠 제거 옻나무 추출물 투여로 생존기간이 연장된 편평세포폐암 환자 1례. 대한암한의학회지 16(2):35-41, 2013
6 김보근, 박상채, 옻나무 전탕추출물 치료를 받은 위암 4기 환자 1례. 대한암한의학회지 18(1):17-22, 2013
7 김보근, 박상채. 옻나무 전탕추출물 한의치료와 항암화학요법을 병용한 대장암 4기 환자 2례. 대한암한의학회지 16(2):63-70, 2011
8 박소정, 강휘중, 박지혜, 조종관, 유화승. 건칠계복정으로 치료한 임상적 진행성 폐암 환자 1례. 대한암한의학회지 20(1):23-29, 2015
9 전형준, 조종관, 이연월, 유화승. 4개월간 한의치료를 받은 전이성 담낭암 환자 증례. 대한한의내과학회지 33(3):338-346, 2012
10 Park JW, Yoon J, Cho CK, Lee YW, Yoo HS. Survival analysis of stage IV metastatic gastric cancer patients treated with HanAm-plus. Chinese journal of integrative medicine. 20(1):49-55, 2014   DOI
11 이동은, 이소영, 김정선, 조종관, 유화승, 최선주. 항암단 및 그 주요성분의 Calu6와 MCF-7 사람 암세포주에 대한 한암효과. 대한한의학회지. 30(5):50-60, 2009
12 이남헌, 윤담희, 유화승, 조정효, 손창규, 이연월, 조종관. 항암단으로 치료한 암환자 100례의 혈청 VFGF, bEGF 및 platelet 수치 변화. 대한한방내과학회지. 26(4):753-760, 2005
13 박지혜. Effects of Samchilchoongcho-Jung (HAD-B1) on A549 Cisplatin-Resistant Lung Cancer Cell Line. 대전대학교 한의학대학원 석사학위 논문. 2015
14 박소정. Anti-Lung Cancer Effect and Toxicological Evaluation of Samchilchoongcho-Jung (HAD-B1). 대전대학교 한의학대학원 박사학위 논문. 2016
15 배겨레, 김지혜, 박지혜, 박소정, 강휘중, 조종관, 유화승. 한방치료로 수술 및 방사선 치료 후 부작용 완화를 이룬 후복막 지방육종환자 2례의 보고. 대한암한의학회지. 20(2):37-49. 2015   DOI
16 유화승, 최정효, 최청광. 소염약침이 암성통증을 수반한 각종 암환자에 미치는 영향. 대한약침학회지. 6(1), 2003
17 유화승 조정효, 이연월, 손창규, 조종관. 약침치료를 이용한 각종 암환자의 임상사례, 대한약침학회지. 7(1):27-36, 2004   DOI
18 김구, 최용석, 주종천, 문구. 산양산삼 약침치료로 종양 퇴축을 보인 폐암환자에 대한 증례보고. 대한약침학회지. 14(4):33-37, 2011   DOI
19 윤호영, 조종관, 유화승. 한방치료를 통해 수술이 불가능한 췌장암 환자에서 통증개선 및 삶의 질을 회복한 증례. 대한암한의학회지. 18(1): 9-15, 2013
20 강영록, 김연진, 황치원. 배대승기탕 보류관장을 시행한 중풍변폐 환자 45례에 대한 임상적 고찰. 대한한방내과학회지. 21(2):329-336, 2000
21 Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Clinical oncology. 2nd ed. p. 2314-2329, New York, Churchill-Livingstone, 2000
22 Nicholas P, Karim F. Carcinoma of unknown primary(CUP). Critical Reviews inn Oncology/Hematology 69:271-278, 2009   DOI
23 보건복지부, 중앙암등록본부, 국립암센터. 국가암등록사업 연례보고서(2012년 암등록통계). 2014
24 Nicholas P. Cancer of unknown primary: biological and clinical characteristics. Annals of Oncology 14 (Suppl 3):iii11-iii18, 2003   DOI
25 Karementz ET, Ceries EJ, Foster DS. Metastases of undetermined source. Curr Probl Cancer 4(5):4-37, 1979   DOI
26 Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Unknown primary carcinoma: natural history and prognostic factors in 675 consecutive patients. J Clinical Oncology 12: 1272-1280, 1994   DOI
27 Nicholas P, Karim F. Carcinoma of unknown primary(CUP). Critical Reviews in Oncology/Hematology 69:271-278, 2009   DOI
28 김지현. 종양학. p. 863, 2012
29 Van de Wouw AJ, Janssen-Heijnen MLG, Coebergh JWW, Hillen HFP. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southern Netherlands, 1984-1992. European Journal of Cancer 38:409-413, 2002   DOI
30 Levi F, Te VC, Erler G, Randimbison L, La Vecchia C. Epidemiology of unknown primary tumours. European Journal of Cancer 38:1810-1812, 2002   DOI
31 조은경, 이근석, 이기형, 정철원, 김원석, 허대석, 방영주, 김노경. 원발부위 불명의 전이암의 예후인자. 대한암학회지 31(99):607-616, 1999
32 Lee JJ, Kim S-Y, Cho KS, Lee J, Yoon HJ. Analysis of 103 patients with unknown primary carcinoma:retrospective study. J Korean Cancer Assoc 33:1-8, 2001
33 Jordan WE 3rd, Shildt PA. Adenocarcinoma of unknown primary site. The Brooke Army Medical Center experience. Cancer 55(4):857-869, 1985   DOI
34 송서영, 김원석, 이혜란, 정현식, 이남수, 오성용, 김지향, 김기현, 남은미, 오영륜, 정철원, 윤성수, 임영혁, 이홍기, 강원기, 박찬형, 박근칠. 원발부위 불명의 선암. 대한내과학회지 61(3):234-239, 2001
35 Greco FA, Hainsworth JD. Poorly differentiated carcinoma or adenocarcinoma of unknown pirmary site: long-term results with cisplatin-based chemotherapy. Semin Oncol 21(5 Suppl 12):77-82, 1994
36 Kim JH, Shin YC, Ko SG. Integrating Traditional Medicine into Modern Inflammatory Disease Care: Multitargeting by Rhus verniciflaua Stokes. Mediators of Inflammation 2014:1-17, 2014
37 Fiore JJ, Kelsen DP, Gralla RJ, Casper ES, Magill G, Cheng E, Ochoa M Jr. Adenocarcinoma of unknown primary origin: Treatment with vindesine and doxorubicin. Cancer Treat Rep 69(6):591-594, 1985
38 Sporn JR, Greenberg BR. Empirical chemotherapy for adenocarcinoma of unknown primary tumor site. Semin Oncol 20(3):261-267, 1993
39 박재현, 문구. 적취를 위주로 한 종양의 치법에 관한 소고. 대한암한의학회지 13(1):1-13, 2008